Eight (11.59%) hits concerned substrate defects, such as fibro-adipose substitution or RV end-diastolic volume (EDV), and they mainly involved genes associated with cardiomyopathies and muscle dysfunction, including TRIM63, MYH6, SGCD and LAMA2. This evidence concerns the gene LAMA2 and cardiomyopathy.